Compare Stocks

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Silver Spruce Resources Inc., an exploration stage company, engages in the exploration of precious and base minerals. The company primarily explores for silver, lead, zinc, copper, gold, and base and rare earth elements. It holds 100% interest in the Pino de Plata project comprising four concessions covering an area of 397 hectors, located in the prolific Sierra Madre Occidental region of Western Chihuahua State in Mexico; and the Melchett Lake property covering an area of 4,698 hectares located within the English River Sub-province of the Archean-age Superior Province. The company also holds options to acquire 50% interest in the Jackie Gold project covering an area of 1,130 hectares located within the west-central portion of the Sierra Madre Occidental Volcanic Complex; and the Diamante project covering an area of 1,057 hectares located near south-southwest of the towns of Tepoca and Carrizal. In addition, it holds an option to acquire 100% interest in the Mystery project covering an area of 8,750 hectares and located near Grand Falls, Newfoundland, Canada. The company was formerly known as First Labrador Acquisitions Inc. and changed its name to Silver Spruce Resources Inc. in October 2004. Silver Spruce Resources Inc. was incorporated in 1996 and is based in Bedford, Canada.

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.